Merck & Co Inc (MIL:1MRKX)
€ 128 -1.34 (-1.04%) Market Cap: 315.02 Bil Enterprise Value: 355.28 Bil PE Ratio: 118.77 PB Ratio: 8.74 GF Score: 57/100

Merck & Co Inc at Wells Fargo Healthcare Conference Transcript

Sep 09, 2026 / 06:15PM GMT
Mohit Bansal
Wells Fargo Securities LLC - Analyst

Great. Thank you for joining us for the afternoon session today. We have team Merck with us. So with us, we have Caroline Litchfield, the CFO of the company. We have Dean Li, the Head of R&D, president of Merck Research and everything.

So thank you very much for joining us today.

Caroline Litchfield
Merck & Co Inc - Executive Vice President, Chief Financial Officer

Thank you for having us.

Mohit Bansal
Wells Fargo Securities LLC - Analyst

So I will turn it over to you, Caroline, to give us the overview of all the great things you are doing at Merck. And yeah, let's just start there.

Caroline Litchfield
Merck & Co Inc - Executive Vice President, Chief Financial Officer

So thank you all for being here today and thank you for your interest in and support of Merck. Since we were here a year ago, we've made tremendous progress. And that progress is all anchored towards driving our long-term growth

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot